Arca
Skip to content
Tools
Tools

GSK3A, GSK3B: Glycogen synthase kinase-3

Family in Homo sapiens that 3 drugs act on.

  • Drugs that act on it: 3
  • Approved: 2
  • In phases 1 to 3: 1
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on GSK3A, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 3

Approved2

  • Lithium carbonate
  • Lithium citrate anhydrous

Phase 30

    Phase 20

      Phase 11

      • AZD-1080

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Glycogen synthase kinase-3 inhibitor.
      Lithium carbonateBoxed warningApprovedSolvaySmall moleculeInhibitor77
      Lithium citrate anhydrousBoxed warningApproved—Small moleculeInhibitor1
      AZD-1080Phase 1—Small moleculeInhibitor0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 9 in all, from ClinicalTrials.gov.
      A Prospective, Randomized, Placebo-Controlled Double Blind, 18 Month Study Evaluating the Efficacy and Tolerability of Lithium Orotate 10 mg Daily in Patients With Alzheimer's Disease and Mild Cognitive Impairment.Lithium carbonate—Not yet recruitingKoser, Robert B., MD PANov 19, 2026
      Wear, Clinical Performance and Computerized Occlusal Evaluation of Hybrid Versus Lithium Disilicates Ceramic CAD/CAM Overlays in Endodontically Treated MolarsLithium carbonateNot applicableNot yet recruitingCairo UniversityNov 17, 2026
      Lithium Dosing StudyLithium carbonateNot applicableNot yet recruitingMassachusetts General HospitalNov 16, 2026
      Smart Sock for Monitoring Walking and Supporting Physical Activity in Older AdultsLithium carbonateNot applicableNot yet recruitingUniversity of MalayaOct 28, 2026
      Clinical Comparison of Lithium Disilicate and 3D-Printed Resin EndocrownsLithium carbonateNot applicableActive, not recruitingMedipol UniversityOct 15, 2026
      Evaluation of Ceramic Dental Crown Clinical Performance After Conventional Hydrofluoric Acid Etching or Gaseous Plasma PretreatmentLithium carbonateNot applicableRecruitingUniversity of Ljubljana, Faculty of MedicineOct 15, 2026
      Clinical Evaluation of 3D-Printed Resin Versus CAD/CAM-Milled Lithium Disilicate Overlay RestorationsLithium carbonateNot applicableEnrolling by invitationTanta UniversityOct 1, 2026
      Conservative Versus Conventional Restorative Approach for Endodontically Treated Posterior TeethLithium carbonateNot applicableRecruitingMoataz Mostafa AnwarSep 23, 2026
      AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With LithiumLithium citrate anhydrousPhase 4Active, not recruitingAssistance Publique - Hôpitaux de ParisSep 16, 2021

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2095188, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.